Article Sidebar
Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Katesjolamiene beskermers en beskadigers van die hart
Abstract
Catecholamine activation enhances the inotropy of the heart by increasing the sarcolemmal influx of Ca2-. This increased influx is counteracted by an increased sarcolemmal efflux and sarcoplasmic reticulum uptake of Ca2+. Thus the intracellular milieu is protected against a gradual rise in Ca2+ concentration. However, under conditions of continuous, excessive catecholamine release, the heart's potential to remove Ca2+ from the cytosol might become exhausted. This might be caused by a Ca2+-dependent exhaustion of high-energy phosphates. As a result of this, Ca2+ overload of the myocytes and eventually a decrease in the pump function of the heart might occur. This paradox has implications for the clinical management of ischaemic heart disease.
